Correspondence 0001193125-23-199389 from SOLENO THERAPEUTICS INC (SLNO) (CIK 0001484565) (SLNO)
SOLENO THERAPEUTICS INC (SLNO) (CIK 0001484565)
Date: July 31, 2023 · CIK: 0001484565 · Accession: 0001193125-23-199389
AI Filing Summary & Sentiment
File numbers found in text: 333-273373
Letter
Re: Soleno Therapeutics, Inc.
July 31, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Abby Adams
Registration Statement on Form S-1
File No. 333- 273373
Acceleration Request
Requested Date: August 2, 2023
Requested Time: 4:00 P.M. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Soleno Therapeutics, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-1 (File No. 333-273373) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff (the “Staff”) of the Division of Corporation Finance of the Securities and Exchange Commission (the “Commission”). Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Jesse Schumaker at (303) 256-5909.
The Company understands that the Staff will consider this request as confirmation by the Company of its awareness of its responsibilities under the federal securities laws as they relate to the offering of the securities covered by the Registration Statements.
[Signature page follows]
* * * *
Sincerely,
Soleno Therapeutics, Inc.
Show Raw Text
CORRESP 1 filename1.htm CORRESP July 31, 2023 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Abby Adams Re: Soleno Therapeutics, Inc. Registration Statement on Form S-1 File No. 333- 273373 Acceleration Request Requested Date: August 2, 2023 Requested Time: 4:00 P.M. Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Soleno Therapeutics, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-1 (File No. 333-273373) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff (the “Staff”) of the Division of Corporation Finance of the Securities and Exchange Commission (the “Commission”). Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Jesse Schumaker at (303) 256-5909. The Company understands that the Staff will consider this request as confirmation by the Company of its awareness of its responsibilities under the federal securities laws as they relate to the offering of the securities covered by the Registration Statements. [Signature page follows] * * * * Sincerely, Soleno Therapeutics, Inc. /s/ Anish Bhatnagar Anish Bhatnagar Chief Executive Officer cc: James Mackaness, Soleno Therapeutics, Inc. Jesse Schumaker, Wilson Sonsini Goodrich & Rosati, P.C. (Signature Page to Acceleration Request Letter)